The latter incorporates a panel of prognostic factors associated with BM from NSCLC on the basis of DS‐GPA, including epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) mutation status. Here, ALK is linked to non-small cell lung carcinoma.